| [O2–17–01]: RESULTS OF A PHASE 1, SINGLE ASCENDING DOSE, PLACEBO‐CONTROLLED STUDY OF ABBV‐8E12 IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY AND PHASE 2 STUDY DESIGN IN EARLY … K Budur, T West, JB Braunstein, I Fogelman, YM Bordelon, I Litvan, ... Alzheimer's & Dementia 13 (7S_Part_12), P599-P600, 2017 | 10 | 2017 |
| [P2–303]: ADVANCING RESEARCH AND TREATMENT IN FRONTOTEMPORAL LOBAR DEGENERATION (ARTFL) NORTH AMERICAN RARE DISEASE CLINICAL RESEARCH CONSORTIUM: PROGRESS AND CHARACTERIZATION … AL Boxer, HJ Rosen, BF Boeve, H Heuer, M Grossman, G Coppola, ... Alzheimer's & Dementia 13 (7S_Part_15), P733-P734, 2017 | | 2017 |
| [P4–189]: SYMPTOM ONSET IN GENETIC FRONTOTEMPORAL DEMENTIA KM Dick, JC van Swieten, A Gerhard, I Le Ber, GB Frisoni, BC Dickerson, ... Alzheimer's & Dementia 13 (7S_Part_28), P1337-P1337, 2017 | 3* | 2017 |
| 100 years and counting: prospects for defeating Alzheimer's disease ED Roberson, L Mucke science 314 (5800), 781-784, 2006 | 747 | 2006 |
| 14-3-3θ does not protect against behavioral or pathological deficits in Alzheimer’s disease mouse models M Gannon, B Wang, SA Stringfellow, S Quintin, I Mendoza, T Srikantha, ... Eneuro 9 (3), 2022 | 2 | 2022 |
| 18F-flortaucipir tau PET distinguishes established progressive supranuclear palsy from controls and Parkinson’s disease: a multicenter study DR Schonhaut, CT McMillan, S Spina, BC Dickerson, A Siderowf, ... Annals of neurology 82 (4), 622, 2017 | 9 | 2017 |
| 18F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study DR Schonhaut, CT McMillan, S Spina, BC Dickerson, A Siderowf, ... Annals of neurology 82 (4), 622-634, 2017 | 164 | 2017 |
| A biochemical blueprint for long-term memory ED Roberson, JD Sweatt Learning & Memory 6 (4), 381-388, 1999 | 71 | 1999 |
| A biochemist's view of long-term potentiation. ED Roberson, JD English, JD Sweatt Learning & Memory 3 (1), 1-24, 1996 | 157 | 1996 |
| A biphasic social dominance phenotype in progranulin-insufficient mice is associated With abnormal cell signaling and neuronal morphology in the amygdala and prefrontal cortex A Arrant, A Filiano, B Warmus, A Hall, E Roberson JOURNAL OF NEUROCHEMISTRY 138, 415-416, 2016 | 1 | 2016 |
| A blood-based signature of cerebrospinal fluid Aβ1–42 status B Goudey, BJ Fung, C Schieber, NG Faux Scientific reports 9 (1), 4163, 2019 | 32 | 2019 |
| A novel Alzheimer disease locus located near the gene encoding tau protein G Jun, CA Ibrahim-Verbaas, M Vronskaya, JC Lambert, J Chung, AC Naj, ... Molecular psychiatry 21 (1), 108-117, 2016 | 291 | 2016 |
| A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity T Rush, JR Roth, SJ Thompson, AR Aldaher, JN Cochran, ED Roberson Neurobiology of disease 134, 104668, 2020 | 27 | 2020 |
| A peptide inhibitor of Tau-SH3 interactions ameliorates Aβ-induced dysfunction and network hyperexcitability JR Roth, T Rush, NVN Carullo, SJ Thompson, AR Aldaher, JS Mesina, ... AAIC Neuroscience Next, 2020 | | 2020 |
| A role for superoxide in protein kinase C activation and induction of long-term potentiation E Klann, ED Roberson, LT Knapp, JD Sweatt Journal of Biological Chemistry 273 (8), 4516-4522, 1998 | 224 | 1998 |
| A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease H Liu, X Zhou, H Jiang, H He, X Liu Scientific reports 6 (1), 26712, 2016 | 15 | 2016 |
| A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease S Salloway, M Farlow, E McDade, DB Clifford, G Wang, JJ Llibre-Guerra, ... Nature medicine 27 (7), 1187-1196, 2021 | 249 | 2021 |
| ABCA7 frameshift deletion associated with Alzheimer disease in African Americans HN Cukier, BW Kunkle, BN Vardarajan, S Rolati, KL Hamilton-Nelson, ... Neurology: Genetics 2 (3), e79, 2016 | 85 | 2016 |
| Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease JJ Palop, J Chin, ED Roberson, J Wang, MT Thwin, N Bien-Ly, J Yoo, ... Neuron 55 (5), 697-711, 2007 | 1715 | 2007 |
| Aberrant regulation of a poison exon caused by a non-coding variant in a mouse model of Scn1a-associated epileptic encephalopathy Y Voskobiynyk, G Battu, SA Felker, JN Cochran, MP Newton, LJ Lambert, ... PLoS genetics 17 (1), e1009195, 2021 | 20 | 2021 |